Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

43.17
-0.6750-1.54%
Volume:5.42M
Turnover:232.88M
Market Cap:62.56B
PE:17.49
High:44.15
Open:43.95
Low:42.46
Close:43.84
52wk High:105.65
52wk Low:41.39
Shares:1.45B
Float Shares:1.45B
Volume Ratio:0.89
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.47
EPS(LYR):1.94
ROE:15.34%
ROA:6.19%
PB:2.51
PE(LYR):22.25

Loading ...

Movement Alert|Boston Scientific Falls 3.07% in Regular Trading, Repeated Price-Target Cuts Weigh on Sentiment

Market Focus
·
Yesterday

Medical Device Makers Slip in Sympathy with J&J's MedTech Miss

Reuters
·
59 mins ago

BTIG Sticks to Their Buy Rating for Boston Scientific (BSX)

TIPRANKS
·
Oct 12

3 Stocks Estimated To Be Trading At Discounts Ranging From 25.7% To 46.4%

Simply Wall St.
·
Oct 12

Boston Scientific Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 10

MedTech Growth Concerns Likely to Overshadow Q3 Results, Leerink Says

Reuters
·
Oct 09

Boston Scientific Corp : Leerink Partners Cuts Target Price to $55 from $60

THOMSON REUTERS
·
Oct 09

Evercore ISI Adjusts Price Target on Boston Scientific to $52 From $65

MT Newswires Live
·
Oct 07

Boston Scientific Appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer

THOMSON REUTERS
·
Oct 07

Boston Scientific Corp - to Establish Three Reportable Segments Effective Jan. 1, 2027

THOMSON REUTERS
·
Oct 07

Boston Scientific Names Joseph Fitzgerald as COO, Effective Jan. 1, 2027

Reuters
·
Oct 07

Boston Scientific Corp. : Barclays Initiates Coverage with Equal-Weight Rating and Target Price $48

THOMSON REUTERS
·
Oct 07

Citigroup Adjusts Price Target on Boston Scientific to $48 From $50, Keeps Neutral Rating

MT Newswires Live
·
Oct 05

Citi cuts Boston Scientific target, opens ‘downside 90-day catalyst watch’

TIPRANKS
·
Oct 05

US Research Roundup-Danaher Corporation, Illumina, Reliance

Reuters
·
Oct 05

Boston Scientific Corp : Bernstein Cuts Target Price to $54 from $60

THOMSON REUTERS
·
Oct 05

Boston Scientific (BSX) Receives a Buy from RBC Capital

TIPRANKS
·
Oct 03

Elutia Receives $8 Million Payment from Boston Scientific; Company NOW Fully Funded into 2029

THOMSON REUTERS
·
Oct 02

Elutia: Continues to Expect Favorable FDA Clearance Decision for NXT-41X in H1 2027

THOMSON REUTERS
·
Oct 02

Press Release: Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029

Dow Jones
·
Oct 02